Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer

Published:2021-03 Issue: Volume:772 Page:145376
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Amini Mohammad,Hejazi Maryam,Ghorban Khodayar,Mokhtarzadeh Ahad,Baradaran Behzad

Funder

Biotechnology Research Center, Tabriz University of Medical Sciences

Aja University of Medical Sciences

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference29 articles.

1. Immune checkpoint inhibitors of PD-L1 as cancer therapeutics;Akinleye;J. Hematol. Oncol.,2019

2. GHSR DNA hypermethylation is a new epigenetic biomarker for gastric adenocarcinoma and beyond;Amini;J. Cell. Physiol.,2019

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

4. Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future;Chen;J. Clin. Investig.,2015

5. Mechanisms regulating PD-L1 expression on tumor and immune cells;Chen;J. ImmunoTher. Cancer,2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving perspectives regarding the role of the PD-1/PD-L1 pathway in gastric cancer immunotherapy;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-01

2. Targeting Pd-L1 Combined with Paclitaxel Hampers Gastric Cancer Progression by Modulating Cell Proliferation, Apoptosis, and Migration;2024

3. Simultaneous suppression of miR-21 and restoration of miR-145 in gastric cancer cells; a promising strategy for inhibition of cell proliferation and migration;BioImpacts;2023-08-07

4. The emerging role of MicroRNA-182 in tumorigenesis; a promising therapeutic target;Cancer Cell International;2023-07-12

5. Immunotherapy through the Lens of Non-Small Cell Lung Cancer;Cancers;2023-05-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3